Sign In
Get Clay Free →

Suggestions

    Stefan Leape

    Chief of Staff at Loyal / Cellular Longevity

    Stefan Leape is a biotech executive with a diverse background in biochemistry, entrepreneurship, and business operations. He served as the Chief of Staff at Cellular Longevity, Inc., doing business as Loyal, from January 2022 to May 2024.4 Leape holds a Master's degree in Biochemistry from the University of Oxford.

    Throughout his career, Leape has held various positions showcasing his expertise:

    1. Co-founder of Operon Technologies in 2018, winning the Grand Prize in the OX1 Incubator program2
    2. President of the Oxford University Biotech Society in 2020, where he founded an 8-week bioentrepreneurship incubator program2
    3. Researcher in metabolic modeling at the University of Oxford's Plant Sciences department2
    4. Summer Associate at Boston Consulting Group (BCG) in 20202
    5. Associate at Hatteras Venture Partners

    Leape has been involved in significant developments in the field of longevity research. In November 2023, while at Loyal, he announced that the FDA had approved the efficacy package for LOY-001, a drug for large dog lifespan extension.1

    As of February 2025, Leape's LinkedIn profile indicates that he is now "Building something new" and is the CEO and co-founder of a Stealth Mode Biotech company.34

    Related Questions

    What are Stefan Leape's main responsibilities at Cellular Longevity, Inc., dba Loyal?
    How did Stefan Leape's role at Boston Consulting Group influence his career?
    What was the significance of Stefan Leape's work at the Oxford University Biotech Society?
    Can you provide more details about the drug LOY-001 and its approval by the FDA?
    What are some of the notable achievements of Operon Technologies under Stefan Leape's leadership?
    Stefan Leape
    Stefan Leape, photo 1
    Stefan Leape, photo 2
    Add to my network

    Location

    San Francisco Bay Area

    Related People

    Related People